US equities |
MU $1,097.39 ▲+3.03% NVDA $230.86 ▲+1.09% SNDK $1,787.69 ▲+2.75% INTC $120.00 ▼-0.19% AAPL $330.32 ▼-0.81% GOOGL $338.24 ▼-1.70% TSLA $354.11 ▼-0.20% AMD $615.73 ▲+0.65%
FinancialContent

IQVIA Holdings, Inc. Common Stock (NY:IQV)

260.72 -8.13 (-3.02%)
Official Closing Price Updated: 7:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
From IQVIA
Via Business Wire
News headline image
IQVIA Announces Pricing of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Announces Offering of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
From IQVIA
Via Business Wire
News headline image
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
From IQVIA
Via Business Wire
News headline image
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
From IQVIA
Via Business Wire
News headline image
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
From IQVIA
Via Business Wire
News headline image
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
From IQVIA
Via Business Wire
News headline image
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
From Medera Inc.
Via GlobeNewswire
News headline image
IQVIA Reports Second-Quarter 2026 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
From IQVIA
Via Business Wire
News headline image
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
From IQVIA
Via Business Wire
News headline image
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
From John Wiley and Sons
Via Business Wire
News headline image
IQVIA Announces Pricing of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Announces Offering of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA CEO to Speak at Jefferies Global Healthcare Conference
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
From IQVIA
Via Business Wire
News headline image
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization
From IQVIA
Via Business Wire
News headline image
IQVIA CFO to Speak at Bank of America Health Care Conference 2026
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Reports First-Quarter 2026 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
From IQVIA
Via Business Wire
News headline image
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference
From IQVIA
Via Business Wire
News headline image
IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Releases its 2025 Sustainability Report
From IQVIA
Via Business Wire
News headline image
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
From IQVIA
Via Business Wire
News headline image
IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions
From IQVIA
Via Business Wire
News headline image
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration
From IQVIA
Via Business Wire
News headline image
IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year
From IQVIA
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >